# A Two Part Trial Investigating the Safety of NN9924 in Healthy Male Subjects

> **NCT01037582** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 155 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2
- Healthy

## Interventions

- **DRUG:** NN9924 (oral)
- **DRUG:** placebo
- **DRUG:** NN9924 (oral)
- **DRUG:** placebo
- **DRUG:** NN9924 (s.c.)
- **DRUG:** NN9924 (i.v.)

## Key facts

- **NCT ID:** NCT01037582
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-17
- **Primary completion:** 2010-05-07
- **Final completion:** 2010-05-07
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2019-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01037582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01037582, "A Two Part Trial Investigating the Safety of NN9924 in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01037582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*